Research programme: antibacterials - AlamX
Alternative Names: Antibacterials research programme - AlamX; Beta-lactamase inhibitors - AlamXLatest Information Update: 23 Aug 2006
At a glance
- Originator AlamX LLC
- Class
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 23 Aug 2006 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 18 Aug 2000 Preclinical development for Bacterial infections in USA (Unknown route)